Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence)
We have collected a total of 26 patients with COVID-19 who required extracorporeal membranous oxygenation (ECMO).
Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients
These initial data may provide useful information to help define the best strategies to care for these challenging patients, and may also provide a framework for much-needed future research about the use of ECMO to treat patients with COVID-19.
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
This case series provides characteristics and early outcomes of sequentially hospitalized patients with confirmed COVID-19 in the New York City area.
COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support
We present the first successful case of VV-ECMO support to recovery of COVID-19 respiratory failure in North America.
Prognosis when Using Extracorporeal Membrane Oxygenation (ECMO) for Critically Ill COVID-19 Patients in China: a Retrospective Case Series
As anticipated, COVID-19 is a pandemic; all healthcare resources are stretched so that ECMO is not a therapy to be rushed to the frontline. Therefore, interim treatment guidelines of recommending ECMO for critically ill COVID-19 patients should be taken cautiously.
CytoSorbents Devices Wins Emergency Approval to Treat COVID-19 Patients
The Food and Drug Administration says it granted Emergency Use Authorization for CytoSorbent’s (NASDAQ:CTSO) CytoSorb device to treat patients with confirmed Covid-19 admitted to the ICU with confirmed or imminent respiratory failure.
Compassionate Use of Remdesivir for Patients with Severe Covid-19
We provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness caused by infection with SARS-CoV-2.
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
We describe a patient with Covid-19 and clinically significant coagulopathy, antiphospholipid antibodies, and multiple infarcts. He was one of three patients with these findings in an intensive care unit designated for patients with Covid-19.
Scavenging Gas Outlet Ports with COVID-19 ECMO and new FDA Recommendations for ECMO
The use of vacuum on the gas outlet port of a membrane oxygenator is a safe practice, if done using vacuum <10 mmHg and tubing with an open leur connector, open wye connector or a cut in the vacuum tubing. It is also advisable to turn the vacuum source off when there is no gas flow through the membrane oxygenator.
Enforcement Policy for Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
The Food and Drug Administration (FDA or Agency) plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.
Sanibel Symposium 2020 Live Webcast with COVID-19 Content
This year's Sanibel Symposium have special focus on COVID-19 with experts from around the world presenting their experiences and suggestions.
Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019
In this survey of heath care workers in hospitals equipped with fever clinics or wards for patients with COVID-19 in Wuhan and other regions in China, participants reported experiencing psychological burden, especially nurses, women, those in Wuhan, and frontline health care workers directly engaged in the diagnosis, treatment, and care for patients with COVID-19.